Doctor profile · Federal record

Dr. Manish Viradia, MD

Neurology Physician (CMS: Neurology) · Annandale, NJ

  • NPI 1457345324
  • Accepts Medicare
  • MIPS 99.1 / 100 · 2023
  • 33 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1322 Route 31
Annandale, NJ 088013127
(908) 894-7222
fax (908) 894-8128
Mailing address
194 Route 31 Ste 102
Flemington, NJ 088225793

Credentials & registration

NPPES · NUCC
NPI registered
September 2005 — 21 yrs on file
Profile last updated
October 25, 2021
Year of graduation
1993 — 33 yrs since
Specialty taxonomy
2084N0400X — NUCC code
State license (1)
New Jersey #25MA07557500

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1457345324. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
172,449
Distinct HCPCS
10
Medicare allowed
$4,719,553
HCPCS Description Services Patients Avg allowed
J0585 Injection, onabotulinumtoxina, 1 unit 73,800 83 $6
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg 64,630 40 $40
J2350 Injection, ocrelizumab, 1 mg 18,600 17 $59
J3032 Injection, eptinezumab-jjmr, 1 mg 10,400 12 $17
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 1,055 47 $22
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 787 62 $72
99214 Established patient office or other outpatient visit, 30-39 minutes 692 468 $141
99213 Established patient office or other outpatient visit, 20-29 minutes 490 243 $99
96375 Injection of additional new drug or substance into vein 398 51 $17
J1200 Injection, diphenhydramine hcl, up to 50 mg 254 46 $1

In context: peer comparison

Among 2 peers in this city , average services per provider: 4,602. This provider delivers 37× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,313
Transactions
187
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 50 $739.17
Lilly USA, LLC 13 $214.86
Amneal Pharmaceuticals LLC 17 $203.31
Teva Pharmaceuticals USA, Inc. 18 $190.25
Eisai Inc. 12 $178.92
PFIZER INC. 12 $171.87
UCB, Inc. 11 $167.78
ARGENX US, INC. 10 $163.71
Biogen, Inc. 9 $162.69
Lundbeck LLC 10 $137.54
EMD Serono, Inc. 7 $108.43
Genentech USA, Inc. 5 $89.07
Novartis Pharmaceuticals Corporation 4 $76.12
Kyowa Kirin, Inc. 5 $71.62
Otsuka America Pharmaceutical, Inc. 4 $61.70

By nature of payment

Food and Beverage
$3,313

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,725
Patients
660
Total drug cost
$1,188,665
Drug Type Claims Patients Total cost
Gabapentin Generic 578 168 $18,141
Pregabalin Generic 310 64 $8,067
Diazepam Generic 228 44 $2,155
Memantine Hcl Generic 219 66 $11,188
Alprazolam Generic 208 55 $1,845
Primidone Generic 178 43 $7,513
Dextroamphetamine-Amphetamine (Dextroamphetamine/Amphetamine) Brand 155 25 $4,638
Butalbital-Acetaminophen-Caffe (Butalb/Acetaminophen/Caffeine) Brand 149 27 $5,560
Carbidopa-Levodopa (Carbidopa/Levodopa) Brand 132 46 $5,935
Topiramate Generic 125 30 $2,487

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Manish Viradia's medical specialty?
Dr. Manish Viradia practices Neurology Physician in Annandale, NJ.
Where does Dr. Manish Viradia practice?
Dr. Manish Viradia practices at 1322 Route 31, Annandale, NJ 088013127. Office phone: 9088947222.
What is Dr. Manish Viradia's NPI?
Dr. Manish Viradia's National Provider Identifier (NPI) is 1457345324, issued by NPPES.
Does Dr. Manish Viradia accept Medicare assignment?
Yes. Dr. Manish Viradia accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Manish Viradia commonly perform?
Top Medicare-reported procedures in 2023: Injection, onabotulinumtoxina, 1 unit (HCPCS J0585); Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS J1568); Injection, ocrelizumab, 1 mg (HCPCS J2350). Source: CMS Medicare Physician & Other Practitioners file.